Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects
An update on a clinical trial studying factors that affect tolerance to nasal birch pollen exposure in older adults with allergic rhinitis a…
-
FDA approval · 2025-04-15FDA Approved: PATADAY TWICE A DAY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application to Pataday Twice a Day Relief (olopatadine hydrochloride) from Alcon Laboratories, expanding the pro…
-
FDA approval · 2025-04-15FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) from Alcon Laboratories, expanding the lab…
-
FDA approval · 2025-04-15FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for PATADAY ONCE DAILY RELIEF (olopatadine hydrochloride) from Alcon Laboratories, Inc.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/Phase 2 methodology development environmental study of reproxalap in subjects with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus [EARLY_Phase 1]
An early Phase 1 trial comparing intracanalicular dexamethasone insert to loteprednol etabonate in keratoconus patients to evaluate safety a…
-
EMA approval · 2025-03-25EMA Authorised: Emadine (emedastine difumarate) — Immedica Pharma AB
The European Medicines Agency authorised Emadine (emedastine difumarate) for allergic conjunctivitis, with Immedica Pharma AB as the marketi…
-
FDA approval · 2025-02-28FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)
The FDA approved Glenmark Therapeutics' olopatadine hydrochloride as an original ANDA, permitting the marketing of a generic product.
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Topical rVA576 for Treatment of Atopic Keratoconjunctivitis [Phase 1, Phase 2]
A Phase 1/2 study of topical rVA576 for atopic keratoconjunctivitis, vernal keratoconjunctivitis, and allergic conjunctivitis was terminated…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber [Phase 1, Phase 2]
This clinical trial update reports that the Reproxalap study in seasonal allergic conjunctivitis completed and results were posted on Februa…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of brimonidine tartrate and ketotifen fumarate for allergic conjunctivitis has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis [Phase 3]
Phase 3 ALLEVIATE trial in allergic conjunctivitis completed with results posted.
-
FDA approval · 2024-12-18FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics' original application for olopatadine hydrochloride ophthalmic solution as a generic treatment for allerg…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis [Phase 2]
A Phase 2 clinical trial evaluating TL-925 for allergic conjunctivitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
This update covers completed clinical trials evaluating an artificial intelligence model designed to diagnose aeroallergies. The model aims …
-
FDA approval · 2024-10-02FDA Approved: ALCAFTADINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for ALCAFTADINE (alcaftadine) by Alembic Pharmaceuticals as a generic ophthalmic solution for allergy-…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) [Phase 4]
Phase 4 study evaluating the effects of desloratadine on ocular signs and symptoms after conjunctival allergen challenge in allergic conjunc…
-
FDA approval · 2024-08-14FDA Approved: BEPOTASTINE BESILATE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for bepotastine besilate, a generic antihistamine for allergic conjunctivitis, submitted by Somers…
-
FDA approval · 2024-08-07FDA Approved: OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for olopatadine hydrochloride ophthalmic solution from Bausch & Lomb, indicating regulatory appr…
-
FDA approval · 2024-07-10FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Padagis US LLC)
FDA approves Padagis US LLC Loteprednol etabonate ophthalmic suspension under an original ANDA application.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of MDI-1228_mesylate ophthalmic solution in healthy adults, with the con…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study Of TL-925 For The Treatment of AC [Phase 2]
TL-925 was evaluated in a Phase 2 trial for allergic conjunctivitis, and the study has completed; the document does not disclose results in …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis [NA]
This clinical trial investigates whether vitamin D supplementation affects corneal epithelial barrier function, the ocular microbiome, ocula…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations
A completed clinical trial from Federico II University evaluated dietary management of cow's milk allergy and whether these dietary choices …
-
FDA approval · 2024-06-05FDA Approved: AZELASTINE HCL — Original Application (Amneal Pharmaceuticals NY LLC)
ANDA approval for AZELASTINE HCL (azelastine) by Amneal Pharmaceuticals NY LLC.